test

Stacy L. Vezina

@Finepoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$1.376BTotal holdings26
Assets growth rate290.61%Assets growth rate (2-Q avg)140.48%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Finepoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Finepoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.376B in assets, with a quarterly growth rate of 290.61% and a 2-quarter average growth rate of 140.48%. The portfolio is managed by Stacy L. Vezina, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
QXOQxo Inc
Recent Activity
New Position
29.52%
$406.09M
25.751M shares@ $15.77 avg price
SPYSpdr S&p 500 Etf Tr
Recent Activity
New Position
23.15%
$318.437M↓ Put
555,000 shares@ $573.76 avg price
IWMIshares Tr
Recent Activity
New Position
17.1%
$235.248M↓ Put
1.065M shares@ $220.89 avg price
LBRDKLiberty Broadband Corp
Recent Activity
11.21%
$154.156M
1.995M shares@ $77.3 avg price
RVMDRevolution Medicines Inc
Recent Activity
Increased 0.35%
2.42%
$33.194M
731,960 shares@ $45.35 avg price
ARGXArgenx Se
Recent Activity
Increased 0.75%
2.15%
$29.504M
54,428 shares@ $542.08 avg price
ASNDAscendis Pharma A S
Recent Activity
Increased 0.43%
2.07%
$28.38M
190,072 shares@ $149.31 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Increased 0.32%
1.82%
$24.934M
1.782M shares@ $13.99 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
Increased 1.96%
1.52%
$20.853M
650,852 shares@ $32.04 avg price
MLTXMoonlake Immunotherapeutics
Recent Activity
1.43%
$19.605M
388,835 shares@ $50.43 avg price